What is the likely diagnosis and appropriate management for a 26‑year‑old postpartum woman with a one‑year anterior neck mass, normal thyroid‑stimulating hormone, elevated free triiodothyronine, and low free thyroxine?

Postpartum Thyroiditis with Evolving Thyroid Dysfunction

This 26-year-old postpartum woman most likely has postpartum thyroiditis transitioning from the hyperthyroid to hypothyroid phase, and requires serial TSH and free T4 monitoring every 2–3 weeks with levothyroxine replacement if TSH remains elevated or symptoms develop. 1, 2

Diagnostic Assessment

Confirming Postpartum Thyroiditis

• Measure TSH, free T4, and antithyroid peroxidase (anti-TPO) antibodies to confirm the diagnosis and assess risk of permanent hypothyroidism 1, 2
• The current laboratory pattern (normal TSH 2.5, low FT4 0.85, previously elevated FT3 4.5) indicates transition from the hyperthyroid phase to the hypothyroid phase of postpartum thyroiditis 1, 2
• Anti-TPO antibodies help confirm the diagnosis and predict long-term risk: women with highest TSH levels and positive anti-TPO antibodies have the greatest risk (20–40%) of developing permanent hypothyroidism within 3–10 years 2

Evaluating the Neck Mass

• Order thyroid ultrasound with evaluation of the central and lateral neck to characterize the one-year anterior neck mass 3
• The American Academy of Otolaryngology recommends neck CT or MRI with contrast for any neck mass present ≥2 weeks, size >1.5 cm, or firm consistency 3
• Perform fine-needle aspiration (FNA) rather than open biopsy if the mass meets high-risk criteria (size >1.5 cm, firm, fixed to adjacent tissues) 3
• Approximately 40% of thyroid nodules identified during pregnancy prove to be malignant, warranting thorough evaluation 1
• Postpartum thyroiditis can rarely present as a cold nodule on thyroid scan, which may evolve to other thyroid conditions 4

Management Strategy

Immediate Management of Hypothyroid Phase

• Initiate levothyroxine replacement if TSH >10 mIU/L regardless of symptoms 2
• Consider levothyroxine if TSH 4–10 mIU/L when the patient is symptomatic or desires fertility 2
• Adjust levothyroxine dosage to return TSH to normal range 2
• Monitor TSH and free T4 every 2–3 weeks to detect spontaneous resolution or progression to permanent hypothyroidism 1, 5, 2

Distinguishing from Graves' Disease

• Obtain TSH receptor antibodies (TRAb) if clinical features suggest Graves' disease rather than postpartum thyroiditis 5
• Red flags for Graves' disease include: ophthalmopathy (proptosis, lid lag), thyroid bruit, persistent hyperthyroidism beyond 6 months postpartum, or recurrent hyperthyroidism after initial resolution 5, 4
• If Graves' disease is confirmed, initiate methimazole therapy (propylthiouracil is reserved for first trimester pregnancy only) 1, 6
• Postpartum thyroiditis can evolve to Graves' disease in rare cases, requiring vigilance for this transition 4

Critical Management Pitfalls to Avoid

Do NOT Use Antithyroid Drugs for Postpartum Thyroiditis

• Thioamides (methimazole, propylthiouracil) are contraindicated in postpartum thyroiditis because this is a destructive inflammatory process, not excessive hormone production 1, 5
• Beta-blockers (atenolol or propranolol) should only be used if hyperthyroid symptoms develop during the thyrotoxic phase 1, 5

Do NOT Dismiss Symptoms as "Normal Postpartum Changes"

• Objective thyroid function testing must guide treatment decisions rather than symptoms alone, because symptom overlap with the normal postpartum period is substantial 2
• Women who develop a goiter during pregnancy or postpartum require TSH and free T4 evaluation 1, 2

Do NOT Delay Evaluation of the Neck Mass

• A one-year anterior neck mass in a young woman warrants imaging and possible FNA to exclude malignancy, particularly given that thyroid carcinoma peaks at age 45–49 in women 3
• The American Academy of Otolaryngology emphasizes that diagnostic delays directly affect tumor stage and worsen prognosis 3

Long-Term Follow-Up

Monitoring for Permanent Hypothyroidism

• Continue monitoring TSH and free T4 at 3-month intervals for the first year, then annually if thyroid function normalizes 2
• Women with the highest TSH elevations and positive anti-TPO antibodies require longer-term surveillance due to 20–40% risk of permanent hypothyroidism 2
• Approximately 8.1% of postpartum women develop thyroid dysfunction, with most cases of postpartum thyroiditis resolving within weeks to months 2

Breastfeeding Considerations

• If levothyroxine is required, it is safe during breastfeeding 1
• If Graves' disease develops requiring thioamide therapy, both methimazole and propylthiouracil are compatible with breastfeeding when used in moderately high doses 1, 5, 6
• Radioactive iodine (I-131) is absolutely contraindicated during breastfeeding; women must wait four months after I-131 treatment before resuming breastfeeding 1, 5